AUTOLOGOUS BONE MARROW TRANSPLANTATION: C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE

自体骨髓移植:C-MYB 反义寡脱氧核苷酸

基本信息

  • 批准号:
    6565777
  • 负责人:
  • 金额:
    $ 12.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-12-01 至 2002-11-30
  • 项目状态:
    已结题

项目摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Selina M Luger其他文献

Evolving Racial/Ethnic Disparities in AML Survival in the Novel Therapy Era: Real-World Evidence of Improved Survival in Older Patients with the Largest Improvement in Non-Hispanic Black Patients
  • DOI:
    10.1182/blood-2023-180185
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Xin Wang;Phyllis Gimotty;Andrew H Matthews;Ronac Mamtani;Selina M Luger;Elizabeth O Hexner;Daria V Babushok;Shannon R McCurdy;Noelle V. Frey;Ximena Jordan Bruno;David L. Porter;Saar Gill;Mary Ellen Martin;Vikram R Paralkar;Ivan Maillard;Alison W Loren;Alexander Perl;Keith W Pratz;Kelly D. Getz;Catherine Lai
  • 通讯作者:
    Catherine Lai
Comparing Cairo Bishop and Howard Criteria for Identifying Clinically Meaningful Tumor Lysis Syndrome Among Acute Myeloid Leukemia Patients Treated with Venetoclax and Hypomethylating Agents: A Single Center Experience
  • DOI:
    10.1182/blood-2023-186978
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Margaret Rowe;Daria V Babushok;Martin Carroll;Alison Carulli;Noelle V. Frey;Saar Gill;Elizabeth O Hexner;Rebecca Hirsh;Nasheed Hossain;Catherine Lai;Alison W Loren;Selina M Luger;Ivan Maillard;Shannon R McCurdy;Andrew H Matthews;Mary Ellen Martin;Vikram R Paralkar;Alexander Perl;David L. Porter;Keith W Pratz
  • 通讯作者:
    Keith W Pratz
Hypomethylating Agents Are Associated with High Rates of Hematologic Toxicity in Patients with Secondary MDS/AML That Develops after Acquired Aplastic Anemia
  • DOI:
    10.1182/blood-2023-179383
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Matthew P Connor;Neeharika Prathapa;Noelle V. Frey;Saar Gill;Elizabeth O Hexner;Ximena Jordan Bruno;Catherine Lai;Alison W Loren;Selina M Luger;Andrew H Matthews;Shannon R McCurdy;Alexander Perl;David L. Porter;Arlene Zeringue;Joseph H. Oved;Timothy S Olson;Keith W Pratz;Daria V Babushok
  • 通讯作者:
    Daria V Babushok
Frail and Pre-Frail Older Adults with Acute Myeloid Leukemia Have Inferior Survival Due to Higher Rates of Disease-Related Deaths
  • DOI:
    10.1182/blood-2023-188978
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Ashley D Hadjis;Griffin W White;Christopher Catania;Noelle V. Frey;Saar Gill;Elizabeth O Hexner;Ximena Jordan Bruno;Catherine Lai;Andrew H Matthews;Mary Ellen Martin;Daria V Babushok;Alexander Perl;David L. Porter;Alison W Loren;Keith W Pratz;Selina M Luger;Shannon R McCurdy
  • 通讯作者:
    Shannon R McCurdy
Older Adults with Acute Myeloid Leukemia (AML) Experience Improvement in Health-Related Quality of Life (HRQoL) Scores with Intensive Therapy: Prospective Study from ECOG-ACRIN (EA) E2906 Phase 3 Trial
  • DOI:
    10.1182/blood-2023-189734
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    James M. Foran;Li Chen;Selina M Luger;Zhuoxin Sun;Heidi Klepin;David F. Claxton;Hillard M. Lazarus;Jacob M. Rowe;Jessica K. Altman;Aref Al-Kali;Hong Zheng;Keith W Pratz;Edward R. Broun;Bayard L Powell;Kristen M. O'Dwyer;Yishai Ofran;John E. Godwin;Mark R. Litzow;Martin S. Tallman;Lynne Wagner
  • 通讯作者:
    Lynne Wagner

Selina M Luger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Selina M Luger', 18)}}的其他基金

C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS
C-MYB 反义寡脱氧核苷酸在慢性粒细胞白血病患者中的应用
  • 批准号:
    6565773
  • 财政年份:
    2001
  • 资助金额:
    $ 12.41万
  • 项目类别:
C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS
C-MYB 反义寡脱氧核苷酸在慢性粒细胞白血病患者中的应用
  • 批准号:
    6468023
  • 财政年份:
    2000
  • 资助金额:
    $ 12.41万
  • 项目类别:
AUTOLOGOUS BONE MARROW TRANSPLANTATION: C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE
自体骨髓移植:C-MYB 反义寡脱氧核苷酸
  • 批准号:
    6468027
  • 财政年份:
    2000
  • 资助金额:
    $ 12.41万
  • 项目类别:
PURGING OF LEUKEMIC BONE MARROW WITH ANTISENSE DNA
用反义 DNA 清除白血病骨髓
  • 批准号:
    2085207
  • 财政年份:
    1993
  • 资助金额:
    $ 12.41万
  • 项目类别:
PURGING OF LEUKEMIC BONE MARROW WITH ANTISENSE DNA
用反义 DNA 清除白血病骨髓
  • 批准号:
    3034746
  • 财政年份:
    1992
  • 资助金额:
    $ 12.41万
  • 项目类别:
EASTERN COOPERATIVE ONCOLOGY GROUP
东方肿瘤合作组
  • 批准号:
    8304351
  • 财政年份:
    1978
  • 资助金额:
    $ 12.41万
  • 项目类别:
EASTERN COOPERATIVE ONCOLOGY GROUP
东方肿瘤合作组
  • 批准号:
    8651973
  • 财政年份:
    1978
  • 资助金额:
    $ 12.41万
  • 项目类别:
EASTERN COOPERATIVE ONCOLOGY GROUP
东方肿瘤合作组
  • 批准号:
    8100410
  • 财政年份:
    1978
  • 资助金额:
    $ 12.41万
  • 项目类别:

相似海外基金

Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
  • 批准号:
    22K09003
  • 财政年份:
    2022
  • 资助金额:
    $ 12.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
  • 批准号:
    21K07762
  • 财政年份:
    2021
  • 资助金额:
    $ 12.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
  • 批准号:
    20K16927
  • 财政年份:
    2020
  • 资助金额:
    $ 12.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
  • 批准号:
    20H00526
  • 财政年份:
    2020
  • 资助金额:
    $ 12.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
  • 批准号:
    20K21245
  • 财政年份:
    2020
  • 资助金额:
    $ 12.41万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
  • 批准号:
    G0900887/1
  • 财政年份:
    2011
  • 资助金额:
    $ 12.41万
  • 项目类别:
    Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
  • 批准号:
    05558090
  • 财政年份:
    1993
  • 资助金额:
    $ 12.41万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
  • 批准号:
    04453031
  • 财政年份:
    1992
  • 资助金额:
    $ 12.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了